Surgery Partners Q2 revenue beats on growth in same-facility segment
SGRY•Drivers of the quarter
- Revenue per case - Same-facility revenue growth of 5.0% was driven mainly by a 4.8% increase in revenue per case, with case volumes nearly flat
- Portfolio optimization - Pending Idaho Falls divestiture cited as a key step in improving the company's financial profile and strategic focus
- Operational initiatives - Management said ongoing operational efficiency efforts and disciplined capital allocation supported performance
Outlook reaffirmed for 2026
- Surgery Partners reaffirms 2026 revenue guidance of $3.35 bln to $3.45 bln
- Company expects 2026 Adjusted EBITDA of at least $530 mln, excluding Idaho Falls divestiture
- Company sees structural tailwinds supporting long-term ASC market growth
Q2 results beat expectations
- US short-stay surgery operator's Q2 revenue rose 2.7%, beating analyst expectations
- Adjusted EPS and Adjusted EBITDA for Q2 beat analyst expectations
- Company reaffirmed 2026 revenue and Adjusted EBITDA outlook, excluding pending Idaho Falls divestiture
| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|
